1. Introduction {#s0005}
===============

There are large diversity of biochemical endpoints which should be available for development of medicinal biochemistry at least via computational models ([@b0160], [@b0065], [@b0070], [@b0120], [@b0045], [@b0165], [@b0135], [@b0075]). Mutagenicity and carcinogenicity are interrelated factors which can catastrophically impact human health ([@b0195]). The necessity to assess risk of applying of various substances in the above aspect is vital necessity ([@b0060]).

There are increase of the number of publications (2012--2017) dedicated to chromosome aberration assay according to PubMed. Importance of systematization of available data and definition of effective strategy for diagnostics and treatment of different cases of breast cancer accompanied by the chromosome aberration is noted by many authors ([@b0085], [@b0010], [@b0090], [@b0130], [@b0220], [@b0215], [@b0020], [@b0155], [@b0030], [@b0015]). The European REACH legislation (Registration, Evaluation, Authorization and Restriction of Chemicals) encourages to improve the safety of chemical substances, increase the research efforts and promote scientific innovation, including the use of alternative approaches to evaluate substances support ([@b0125]). Among the in vitro tests required to identify mutagenic compounds, bacterial reverse mutation assay (Ames test) ([@b0005]) and chromosome aberration test are frequently used in the first stages of the assessment for mutagenicity.

It is to be noted that in spite of high influence of REACH legislation there are negative tendencies caused by REACH: (1) The registration process is very expensive, due to the high degree of experimental and administrative work required; and (2) At social level, REACH raises the ethical problem caused by the huge amount of animal testing necessary to meet the requirements of REACH [@b0080].

More than 25 years ago, the OECD recognized the need to protect animals in general and, in particular, those used in experimental work. The progress in OECD on the harmonization of chemicals control, especially the agreement on Mutual Acceptance of Data (MAD), has greatly contributed to reduce the number of animals used in testing by avoiding duplicative testing.

All OECD Test Guidelines (TGs) are available at the OECD website (http://www.oecd.org/env/ehs/testing/oecdguidelinesforthetestingofchemicals.htm).

In the first case, the genotoxic potential of a target compound is determined by the detection of the renewed functional capability to synthesize the essential amino acid of an auxotrophic histidine-dependent strain of *S. typhimurium*. At the presence of that mutagen, the revertant bacteria can grow up on a medium without histidine ([@b0110]). In vitro chromosome aberration assay is used to identify agents that cause structural aberrations in mammalian cells. As for the Ames test, the target compounds are examined with and without metabolizing system since often the interaction with genetic material occurs after metabolic activation. After incubation with the chemical target at intended intervals, the cells are arrested in metaphase and analyzed microscopically looking for chromosomal aberrations.

Many human genetic diseases are caused by chromosome mutations and there is evidence that they are also involved in the alterations of oncogenes and tumor suppressor genes of somatic cells in humans and experimental animals ([@b0115]). Chromosomal aberrations in peripheral blood lymphocytes have been used for decades for the surveillance of healthy individuals exposed to known or potential mutagens and carcinogens ([@b0015], [@b0025]). In addition, chromosome aberrations are typical features of neoplastic cells, and for certain cancers specific chromosome abnormalities are commonly present ([@b0230]).

Although specific chromosome aberrations detected in neoplasms are generated during carcinogenesis, it has been hypothesized that the frequency of chromosomal aberrations represents a marker of susceptibility to cancer, based on the concept that genetic damage in peripheral blood lymphocytes reflects similar damage in different target cells undergoing carcinogenesis ([@b0025], [@b0205]). Moreover, the chromosome aberration test is an important parameter of a substance also from the point of view of drug discovery ([@b0105]), cosmetics, and food industry (https://www.fda.gov/downloads/Drugs/Guidances/ucm074931.pdf).

Due to their publicly and high quality availability, Ames test data have been used to develop several QSAR models that, during the last years, showed good performance predicting mutagenic activity ([@b0035]). In the case of the chromosomal aberration endpoint, the predictive models are few. This is probably due to the complexity of mechanism of its induction and the lower availability of high-quality experimental data. In addition, there are different models of the chromosome aberration test which involve topological indices together with physicochemical and biochemical parameters to build up a model ([@b0210], [@b0095], [@b0150], [@b0100], [@b0140], [@b0145], [@b0050]).

However, often, the involving of physicochemical and biochemical parameters is unavailable. Consequently, the using solely molecular structures without additional data is an attractive alternative for building up a model of chromosome aberration test. The CORAL (CORrealtion And Logic) software allows building up models of this kind. The aim of this study is the estimation of models for chromosome aberration test which are built up using the CORAL software ([@b0195]).

2. Method {#s0010}
=========

2.1. Data {#s0015}
---------

Experimental data for this work were taken from the Genotoxicity OASIS Database (http://oasis-lmc.org/products/databases/rat-liver-metabolism-extended.aspx) and the Toxicity Japan MHLW (http://dra4.nihs.go.jp/mhlw_data/jsp/SearchPageENG.jsp) that include data for chromosomal aberrations determined by in vitro test using Chinese hamster lung (CHL) and ovary (CHO) cells, with and without metabolic activation (metabolic system S9).

After removing duplicates we collected a set of 477 organic compounds: 223 are classified as active and 254 are classified as inactive in chromosomal aberrations test. For each compound, CAS number, simplified molecular input-line entry system (SMILES) and experimental data expressed as active (+1) or inactive (−1) are represented. Finally, SMILES have been normalized by the VEGA platform (www.vega-qsar.eu/). These compounds were randomly split into the training (80%), calibration (10%), and validation (10%) sets (five splits are examined).

The CORAL software is developed with taking into account the following hypothesis: QSAR model is a random event ([@b0185]). In other words, the same approach that is used to build up a QSAR model gives quite different models for different splits into the training set and validation set. Thus, lucky splits (good statistical quality) and unlucky splits (poor statistical quality) take place for any total set that is used for the QSAR analysis. Consequently, in order to check up an approach really, one should examine a group of different distributions of available data into the training set (visible during building up a model) and the validation set (invisible during building up a model). This experiment confirms that there are lucky and unlucky splits, especially if large number of different splits are examined.

2.2. Optimal descriptor {#s0020}
-----------------------

The optimal descriptor used in this work is calculated as the following:$$\mathit{DCW}(T^{\ast}\text{,}N^{\ast}) = \sum\mathit{CW}(S_{k}) + \sum\mathit{CW}(\mathit{SS}_{k}) + \mathit{CW}(\mathit{HARD})$$

Simplified molecular input-line entry system (SMILES) ([@b0225]) is used to represent the molecular structure via SMILES attributes. In this work, two local SMILES attributes (*S~k~* and *SS~k~*) and one global SMILES attribute (HARD) are involved to build up predictive models.

The *S~k~* are SMILES atoms, i.e. one symbol from SMILES or two symbols which cannot be examined separately, e.g. 'Cl', 'Br', etc. The *SS~k~* are combines of two SMILES atoms. The HARD is global SMILES attribute, which reflects presence (absence) of Nitrogen, Oxygen, Sulphur, Phosphorus, Chlorine, Fluorine, Bromine, Iodine, double and triple covalent bonds ([@b0185], [@b0190], [@b0170]). [Table 1](#t0005){ref-type="table"} contains example of definition for *S~k~*, *SS~k~*, and HARD. The T is threshold, i.e. integer to discriminate all SMILES attributes into two classes (i) rare, i.e. the number of the given attribute in the training set is less than threshold; and (ii) not rare, i.e. the number of given attribute in the training set is larger (or at least equal) than threshold. The N is the number of epochs of the Monte Carlo optimization of the target function ([@b0185]). The T = T∗ and N = N∗ are values of the parameters which give the best statistics for the calibration set. So-called semi-correlation ([@b0175], [@b0200]) has been used to build up predictive models for chromosomal aberrations test. [Fig. 1](#f0005){ref-type="fig"} elucidates the interrelations between semi-correlation and binary classification model. [Fig. 2](#f0010){ref-type="fig"} contains an example of the model for chromosome aberration test.Table 1Examples of the Sk, SSk, and HARD for molecular structure represented by the following SMILES O = \[N+\](\[O−\])c1ccc(cc1)Cl.*S~k~SS~k~*O\...\...\.....=\...\...\.....O\...=\...\....\[\...\...\.....\[\...=\...\....N\...\...\.....\[\...N\...\....+\...\...\.....N\...+\...\....\[\...\...\.....\[\...+\...\....(\...\...\.....\[\...(\...\....\[\...\...\.....\[\...(\...\....O\...\...\.....\[\...O\...\....−\...\...\.....O\...−\...\....\[\...\...\.....\[\...−\...\....(\...\...\.....\[\...(\...\....c\...\...\.....c\...(\...\....1\...\...\.....c\...1\...\....c\...\...\.....c\...1\...\....c\...\...\.....c\...c\...\....c\...\...\.....c\...c\...\....(\...\...\.....c\...(\...\....c\...\...\.....c\...(\...\....c\...\...\.....c\...c\...\....1\...\...\.....c\...1\...\....(\...\...\.....1\...(\...\....Cl\...\...\....Cl..(\...\....=\#\@NOSPFClBrIHARD\$10011000100Fig. 1Interpretations for traditional correlation and semi-correlation.Fig. 2Graphical representation of semi correlations for split 2 ("lucky split") and statistical characteristics of this model for chromosome aberration test. TP = true positive; TN = true negative; FP = false positive; and FN = false negative.

2.3. Statistical criteria {#s0025}
-------------------------

In order to build up classification model i.e. separation of two classes (i) active (1); and (ii) inactive (−1) ([@b0200]), the following statistical criteria have been used: sensitivity, specificity, accuracy, and Mattews correlation coefficient (MCC).$$\mathit{Sensitivity} = \frac{\mathit{TP}}{\mathit{TP} + \mathit{FN}}$$$$\mathit{Specificity} = \frac{\mathit{TN}}{\mathit{TN} + \mathit{FP}}$$$$\mathit{Accuracy} = \frac{\mathit{TP} + \mathit{TN}}{\mathit{TP} + \mathit{FP} + \mathit{FN} + \mathit{TN}}$$$$\mathit{MCC} = \frac{\mathit{TP} \times \mathit{TN} - \mathit{FP} \times \mathit{FN}}{\sqrt{(\mathit{TP} + \mathit{FP})(\mathit{TP} + \mathit{FN})(\mathit{TN} + \mathit{FP})(\mathit{TN} + \mathit{FN})}}$$

In these equations TP, TN, FP and FN represent the number of true positives, true negatives, false positives and false negatives, respectively, in a confusion matrix.

The MCC coefficient is used in machine learning as a balanced measure of the quality of binary classifications and it is useful even if the classes are of very different sizes ([@b0040]).

A model is good if MCC → 1 (in praxis, the MCC should be larger than 0.6).

2.4. Domain of applicability {#s0030}
----------------------------

Domain of applicability is important component of a QSAR analyses. Diversity of QSAR approaches cause the diversity of conceptions for domain of applicability. A collection of conceptions of domain of applicability is available in literature ([@b0055]): (i) Chemical-physical domain; (ii) Structural domain; (iii) Response domain; and (iv) Integrated methods.

However, in the case of the CORAL models, the statistical defects of SMILES calculated according to distribution of available data into the training, invisible training, calibration, and validation sets are the basis to define domain of applicability. The defect of SMILES attribute is defined via the difference of the probability of the attribute in the training set and probability of the attribute in the calibration set. The SMILES-defect is the summation of these defects of attributes. If a SMILES is characterized by the SMILES-defect which is lower than the doubled average defect over compounds of the training set, the SMILES falls into the domain of applicability, otherwise the SMILES is out of the domain of applicability ([@b0200]):$$\mathit{Attribute}\_\mathit{Defect} = \frac{\left| {P\left( A \right) - P^{'}\left( A \right)} \right|}{N\left( A \right) + N^{'}\left( A \right)}$$The P(A) and P′(A) are probabilities of attribute A in the training and calibration sets, respectively. The N(A) and N′(A) are frequencies of A in the training and calibration sets, respectively.$$\mathit{SMILES}\_\mathit{Defect} = \sum\limits_{k = 1}^{\mathit{NA}}\mathit{Attribute}\_\mathit{Defect}\lbrack k\rbrack$$

The NA is the number of attributes in a SMILES.$$\mathit{Domain}\ \mathit{Applicability} = \left\{ \begin{array}{l}
{\mathit{YES}\text{,}\ \mathit{if}\ \mathit{SMILES}\_\mathit{Defect} < 2^{\ast}\bar{\mathit{SMILES}\_\mathit{Defect}}\ } \\
{\mathit{NO}\text{,}\ \mathit{if}\ \mathit{SMILES}\_\mathit{Defect} > 2^{\ast}\bar{\mathit{SMILES}\_\mathit{Defect}}} \\
 \\
\end{array} \right)$$$\mathit{The}\ \bar{\mathit{SMILES}\_\mathit{Defect}}$ is average *SMILES_defect* over training set.

3. Results and discussion {#s0035}
=========================

[Table 2](#t0010){ref-type="table"} contains the statistical characteristics for models of chromosome aberration test built up with the CORAL software. [Table 3](#t0015){ref-type="table"} contains the statistical characteristics for models suggested in the literature. One can see that the CORAL models are satisfactory and comparable with the analogical models from the literature. Results for the training set are in the range of 0.67--0.76 for sensitivity. Better results have been always obtained for specificity, with values reaching 0.83. The values for accuracy are of course between those of sensitivity and specificity, within a very sharp range, between 0.76 and 78. Indeed, the split 5, which has the lowest sensitivity value, has the highest specificity value, while split 1, with the highest sensitivity value, has a relatively low specificity value. As it often happens with CORAL, highest statistical parameters have been obtained with the calibration set. Better results for specificity are observed on the validation set, with values in the range between 0.81 and 1.0.Table 2The statistical quality of models for chromosome aberration test.SplitSetnSensitivitySpecificityAccuracyMCC1Training3990.75920.79810.77940.5578Calibration390.83330.86670.84620.6868Validation390.87500.83870.84620.6244  2Training4070.70160.80090.75430.5059Calibration350.93750.94710.94290.8849Validation350.87501.0000.94290.8898  3Training3800.73480.78890.76320.5248Calibration490.93330.82350.85710.7097Validation480.81481.0000.89580.8112  4Training3980.75130.77070.76130.5221Calibration400.94120.95650.95000.8977Validation391.0000.69230.79490.6574  5Training3990.67420.83260.76190.5156Calibration390.76001.0000.84620.7294Validation390.85000.94740.89740.7995Table 3The statistical quality of models for chromosome aberration test suggested in the literature.ReferenceSetnSensitivitySpecificityAccuracyMulticase methodology [@b0145]Training5370.528[ª](#tblfn1){ref-type="table-fn"}0.75[ª](#tblfn1){ref-type="table-fn"}0.649[ª](#tblfn1){ref-type="table-fn"}Internal Validation530.568[ª](#tblfn1){ref-type="table-fn"}0.717[ª](#tblfn1){ref-type="table-fn"}0.651[ª](#tblfn1){ref-type="table-fn"}Machine learning [@b0145]Training5210.751[b](#tblfn2){ref-type="table-fn"}0.768[b](#tblfn2){ref-type="table-fn"}0.76[b](#tblfn2){ref-type="table-fn"}Validation580.708[b](#tblfn2){ref-type="table-fn"}0.714[b](#tblfn2){ref-type="table-fn"}0.716[b](#tblfn2){ref-type="table-fn"}[@b0140]Dataset in 9 cross-validation folds1900.540.700.62(KNN) [@b0150]Training3460.6930.8610.812Validation370.7270.9230.865(SVM) [@b0150]Training3080.98910.997Cross-validation380.72710.921Validation370.7270.8850.838[@b0050]Training2160.8490.8690.86Validation1560.8180.8290.828[^1][^2]

The basic hypothesis for the CORAL software is "the good statistical quality of a model for calibration set should be accompanied by the good statistical quality of the model for external validation set". According this conception the best CORAL model observes for split \#4 (MCC = 0.8977). However, for other splits the MCC is quite satisfactory with values larger than 0.6.

The fluctuations of the different splits are due to the relatively limited number of chemicals. In these circumstances, only a few substances, which are false positives or false negatives in one or the other split, have high impact on the statistical values. Anyhow, the five splits provide a realistic scenario of the possible expected results in different cases. The general picture of the data indicate that the values are always good, for all criteria examined here.

The statistical parameters of other models published in the literature are quite similar to those we obtained. The best published model ([@b0145]) gave sensitivity for the training set of 0.75. The CORAL-model gives similar quality (0.76). The specificity of the CORAL-model is higher. The model by [@b0140] has low statistical quality, quite similar to the model developed by [@b0145] through Multicase methodology. In addition, the CORAL shows better predictive potential for the validation set than the model by Estrada [@b0050]. The Support Vector Machine described by [@b0150]) gives prediction poorer that the CORAL. Thus, the CORAL software gives useful predictions for examined endpoint.

4. Conclusions {#s0040}
==============

The suggested models are built up according to OECD principles. The statistical quality of the models is comparable with similar models suggested in the literature. The semi-correlation is special category used in the CORAL software to build up the binary classifications, in form Yes/No, Active/Inactive. Factually, the approach (semi-correlations) has no analogies. However there are successful attempts to use the approach as a tool of SAR analysis ([@b0175], [@b0180], [@b0200]). The principle "QSAR is a random event" is confirmed for the case of the semi-correlations developed for different splits into the training and validation sets ([Table 2](#t0010){ref-type="table"}). In other words, the predictive potential of the semi-correlations takes place for all splits, but there are dispersion of statistical characteristics for different splits: there are lucky splits (e.g. \#2) and there are unlucky splits (e.g. \#1).
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[^1]: Mean value of 10 indipendent validations.

[^2]: Values represent mean ± standard deviation of 20 indipendent validations.
